320 related articles for article (PubMed ID: 19967722)
21. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of caspase-14 gene in common carcinomas.
Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
[TBL] [Abstract][Full Text] [Related]
23. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.
Lee SH; Shin MS; Park WS; Kim SY; Kim HS; Han JY; Park GS; Dong SM; Pi JH; Kim CS; Kim SH; Lee JY; Yoo NJ
Oncogene; 1999 Jun; 18(25):3754-60. PubMed ID: 10391683
[TBL] [Abstract][Full Text] [Related]
24. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
25. Genotype analysis of the NRF2 gene mutation in lung cancer.
Sasaki H; Suzuki A; Shitara M; Hikosaka Y; Okuda K; Moriyama S; Yano M; Fujii Y
Int J Mol Med; 2013 May; 31(5):1135-8. PubMed ID: 23545629
[TBL] [Abstract][Full Text] [Related]
26. Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis.
Gupta R; Singh S; Hedau S; Nigam S; Das BC; Singh I; Mandal AK
J Clin Pathol; 2007 May; 60(5):472-5. PubMed ID: 16731596
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
Cheng KA; Kurtis B; Babayeva S; Zhuge J; Tantchou I; Cai D; Lafaro RJ; Fallon JT; Zhong M
Ann Diagn Pathol; 2015 Jun; 19(3):146-8. PubMed ID: 25862495
[TBL] [Abstract][Full Text] [Related]
28. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin.
Kubo Y; Urano Y; Hida Y; Arase S
J Dermatol Sci; 1999 Apr; 19(3):199-201. PubMed ID: 10215192
[TBL] [Abstract][Full Text] [Related]
29. Mutational and expressional analyses of STAG2 gene in solid cancers.
Kim MS; Kim SS; Je EM; Yoo NJ; Lee SH
Neoplasma; 2012; 59(5):524-9. PubMed ID: 22668012
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y
Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339
[TBL] [Abstract][Full Text] [Related]
31. MRP3 gene expression correlates with NRF2 mutations in lung squamous cell carcinomas.
Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y
Mol Med Rep; 2012 Oct; 6(4):705-8. PubMed ID: 22767273
[TBL] [Abstract][Full Text] [Related]
32. Increased NRF2 gene (NFE2L2) copy number correlates with mutations in lung squamous cell carcinomas.
Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y
Mol Med Rep; 2012 Aug; 6(2):391-4. PubMed ID: 22614957
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma.
Nakajima M; Fukuchi M; Miyazaki T; Masuda N; Kato H; Kuwano H
Br J Cancer; 2003 Jun; 88(11):1734-9. PubMed ID: 12771989
[TBL] [Abstract][Full Text] [Related]
34. A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue.
Bowman BM; Montgomery SA; Schrank TP; Simon JM; Ptacek TS; Tamir TY; Mulvaney KM; Weir SJ; Nguyen TT; Murphy RM; Makowski L; Hayes DN; Chen XL; Randell SH; Weissman BE; Major MB
J Pathol; 2020 Oct; 252(2):125-137. PubMed ID: 32619021
[TBL] [Abstract][Full Text] [Related]
35. Mutational and expressional analyses of NRF2 and KEAP1 in sarcomas.
Je EM; An CH; Yoo NJ; Lee SH
Tumori; 2012; 98(4):510-5. PubMed ID: 23052169
[TBL] [Abstract][Full Text] [Related]
36. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
Zhou Y; Sinha S; Schwartz JL; Adami GR
BMC Cancer; 2019 Jun; 19(1):607. PubMed ID: 31221127
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.
Oh JE; Kim MS; Ahn CH; Kim SS; Han JY; Lee SH; Yoo NJ
Pathology; 2010 Jan; 42(1):73-6. PubMed ID: 20025484
[TBL] [Abstract][Full Text] [Related]
38. Mutational and expressional analyses of MYD88 gene in common solid cancers.
Je EM; Kim SS; Yoo NJ; Lee SH
Tumori; 2012; 98(5):663-9. PubMed ID: 23235763
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus.
Mayama T; Mori T; Abe K; Sasano H; Nishihira T; Satomi S; Horii A
Eur J Surg Oncol; 1997 Aug; 23(4):298-303. PubMed ID: 9315056
[TBL] [Abstract][Full Text] [Related]
40. Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations.
Rolfs F; Huber M; Kuehne A; Kramer S; Haertel E; Muzumdar S; Wagner J; Tanner Y; Böhm F; Smola S; Zamboni N; Levesque MP; Dummer R; Beer HD; Hohl D; Werner S; Schäfer M
Cancer Res; 2015 Nov; 75(22):4817-29. PubMed ID: 26530903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
